Risk of Coeliac Disease After Immune Checkpoint Inhibitor Exposure in Patients With Cancer. (PubMed, Aliment Pharmacol Ther) - Sep 11, 2026 - "In this large real-world cohort, ICI exposure was associated with nearly a fourfold increase in the risk of being diagnosed with CeD compared with matched controls."
Checkpoint inhibition • Journal • Celiac Disease • Gastrointestinal Disorder • Immunology • Oncology
|
|
Adam C Bledsoe; Joseph A Murray; Razan Aburumman; Rok Seon Choung; Saqr Alsakarneh
|